The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer’s disease
Open accessAbstract
Background: Patient-to-patient variability in the degree to which β-amyloid, tau and neurodegeneration impact cognitive decline in Alzheimer’s disease (AD) complicates disease modeling and treatment. However, the underlying mechanisms leading to cognitive resilience are not resolved. We hypothesize that the variability in cognitive function and loss relates to neuronal resilience of the hippocampal GABAergic network. Methods: We compared TgF344-AD and non-transgenic littermate rats at 9, 12, and 15 months of age. Neurons, β-amyloid plaques and tau inclusions were quantified in hippocampus and entorhinal cortex. Somatostatin (SST) and parvalbumin (PVB) interneurons were traced to examine hippocampal neuroplasticity and cognition was tested in the Barnes maze. Results: The 9-month-old TgF344-AD rats exhibited loss of neurons in the entorhinal cortex and hippocampus. Hippocampal neuronal compensation was observed in 12-month TgF344-AD rats, with upregulation of GABAergic interneuronal marker. By 15 months, the TgF344-AD rats had robust loss of excitatory and inhibitory neurons. β-Amyloid and tau pathology accumulated continuously across age. SST interneurons exhibited tau inclusions and atrophy from 9 months, whereas PVB interneurons were resilient until 15 months. The hippocampal PVB circuit underwent neuroplastic reorganization with increased dendritic length and complexity in 9- and 12-month-old TgF344-AD rats, before atrophy at 15 months. Strikingly, 12-month-old TgF344-AD rats were resilient in executive function and cognitive flexibility. Cognitive resilience in TgF344-AD rats occurred as maintenance of function between 9 and 12 months of age despite progressive spatial memory deficits, and was sustained by PVB neuroplasticity. Conclusions: Our results demonstrate the inherent neuronal processes leading to cognitive maintenance, and describe a novel finding of endogenous cognitive resilience in an AD model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig. 3 Linear Aβ deposition and exponential tau accumulation across disease progression in TgF344-AD rats. Aβ and tau pathology were assessed in the hippocampus (HP) and entorhinal cortex (EC) of 9-, 12- and 15-month-old TgF344-AD rats (n = 5–6 rats/age). a Representative HP and EC images of 6F3D staining for Aβ demonstrate extensive plaque coverage at 15 months of age. b PHF1 staining indicates dystrophic neurites [plaque-associated (PA)] and tangle inclusions [non-plaque-associated (NPA); inset] of hyperphosphorylated tau. c Quantification of plaque coverage in HP and EC demonstrates linear accumulation of Aβ across age. NPA (d) and PA (e) tau inclusions also increased with age but in an exponential manner, notably between 12 and 15 months of age, and to a significantly greater degree in EC than HP. f Quantification of PA inclusions per plaque in CA1, DG and EC determined significant effects of age and region on plaque area covered by tau dystrophic neurites (n = 30 plaques/region in each cohort of 5 rats/age). Significantly greater plaque area was covered by tau inclusions in EC compared to DG and CA1 at all ages, and DG compared to CA1 at 9 and 12 months. g Linear relationship between plaque size and number of tau-positive dystrophic neurites, demonstrating significantly more neurites per plaque with age, most prominently at 15 months (9-month: Y = 0.003 X + 4.52; 12-month: Y = 0.004 X + 6.15; 15-month: Y = 0.009 X + 2.57; n = 90 plaques in each cohort of 5 rats/age). Scale bars, 200 μm (a) and 20 μm (b). Data are mean ± SEM (f) or 95% confidence intervals (c–e, g); two-way ANOVA with Holm-Sidak post hoc test (f), linear regression (c, g), non-linear exponential growth regression (d, e); *P < 0.05, **P < 0.01, ***P < 0.001](/paper-figures/e717c9fde5424417be273e05f41169ca/parvalbumin-neuroplasticity-compensates-for-somatostatin-impairment-maintaining-figure-3.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recently, it has been shown that SOMs are more vulnerable than other inhibitory neurons, such as parvalbumin neurons, in TgF344-AD rats [49].”
From Abnormal accumulation of extracellular vesicles in hippocampal dystrophic axons and regulation by the primary cilia in Alzheimer's disease (2023) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 3×
“Notably, tau pathology in TgF344-AD rats occurs in response to Aβ-induced neuronal damage, and is composed of physiologically-expressed, endogenous rat tau that is hyperphosphorylated and aggregates in patterns akin to Braak staging [20, 21, 25].”
BackgroundResultThe amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Cognitive reserve in ageing and Alzheimer's disease
Stern, Y. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70191-6 · Cited by 3,557 · cited 2×
“Cognitive reserve refers to the variability between individuals to withstand greater degrees of neurodegeneration before exhibiting cognitive impairment [16].”
BackgroundPhases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
GABAergic Interneurons in the Neocortex: From Cellular Properties to Circuits
Tremblay, R., Lee, S., & Rudy, B. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.033 · Cited by 2,033
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
Memory and Executive Function in Aging and AD
Buckner, R. L. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.006 · Cited by 1,508
Verret, L., Mann, E. O., Hang, G. B., Barth, A. M. I., Cobos, I., Ho, K., Devidze, N., Masliah, E., Kreitzer, A. C., Mody, I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.046 · Cited by 1,216
Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer’s Disease
Busche, M. A., Eichhoff, G., Adelsberger, H., Abramowski, D., Wiederhold, K.-H., Haass, C., Staufenbiel, M., Konnerth, A., & Garaschuk, O. (2008) · Science · doi:10.1126/science.1162844 · Cited by 1,125
Network abnormalities and interneuron dysfunction in Alzheimer disease
Palop, J. J., & Mucke, L. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.141 · Cited by 1,022
Cited by
van den Berg, M., Toen, D. V., Verhoye, M., & Keliris, G. A. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1081058 · Cited by 43
Factors Affecting Resilience and Prevention of Alzheimer's Disease and Related Dementias
Masurkar, A. V., Marsh, K., Morgan, B. E., Leitner, D., & Wısnıewskı, T. (2024) · Annals of Neurology · doi:10.1002/ana.27055 · Cited by 46
“137 Other studies have pointed to interneurons as another important locus of compensatory response, via upregulation of GABA receptors, 138 structural plasticity of one interneuron population to counter the loss of another interneuron class, 139 and increased integrity in response to enrichment.”
Zhang, S., Wu, Z., Zhang, S., Ru, Y., Wang, Q., Tong, H., Qin, Q., Yan, Q., Li, Z., & Wu, G. (2025) · Food & Function · doi:10.1039/d5fo03139g · Cited by 41
The hippocampus associated GABAergic neural network impairment in early-stage of Alzheimer's disease
Tang, Y., Yan, Y., Mao, J., Ni, J., & Qing, H. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101865 · Cited by 37
Hernández‐Frausto, M., Bilash, O. M., Masurkar, A. V., & Basu, J. (2023) · Frontiers in Neural Circuits · doi:10.3389/fncir.2023.1223891 · Cited by 39
“, 2018), and SST INs loss appears in the mouse 5xFAD and PS1xAPP and rat TgF344-AD models (Ramos et al., 2006; Li et al., 2022; Morrone et al., 2022).”
Metadata
- Authors
- Morrone, C. D., Lai, A. Y., Bishay, J., Hill, M. E., & McLaurin, J.
- Affiliations
- Sunnybrook Research Institute (CA)
- University of Toronto (CA)
- Corresponding author
- Morrone, Christopher Daniel
- ORCID
- Venue
- Translational Neurodegeneration
- Published
- 2022-05-03
- Volume
- 11
- Issue
- 1
- Pages
- 26-26
- ISSN
- 2047-9158 (ISSN-L)
- PMC
- PMC9063209
- OpenAlex
- W4225323985
- Cited by
- 43
- References
- 66
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 14 · 2023: 9 · 2022: 2
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Translational Neurodegeneration (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (PJY155983)
- Foundation for the National Institutes of Health (R01 AG057665-02)
- Canada Research Chairs
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, cognitive resilience, parvalbumin interneurons, somatostatin interneurons, hippocampal plasticity, TgF344-AD rat model, amyloid plaques, tau inclusions, entorhinal cortex atrophy, dendritic complexity, spatial memory impairment, executive function, cognitive flexibility
- MeSH terms
- Alzheimer Disease, Animals, Atrophy, Cognition, Disease Models, Animal, Humans, Neuronal Plasticity, Parvalbumins, Rats, Inbred F344, Somatostatin, Amyloid beta-Peptides, Rats, Rats, Transgenic, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer’s disease. https://app.cochat.ai/papers/10.1186/s40035-022-00300-6
- The paper
- Morrone, C. D., Lai, A. Y., Bishay, J., Hill, M. E., & McLaurin, J. (2022). Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer’s disease. Translational Neurodegeneration. https://doi.org/10.1186/s40035-022-00300-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.